BioInvent International AB (publ) Current Assets

The latest current assets for 0H22.L is $380M as of June 2026. That compares with $880M in the prior-year period — down 56.9% year over year. Investors often review this figure alongside BioInvent International AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 0H22.L's current assets moved from $880M to $380M — a 56.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioInvent International AB (publ)'s operating scale or balance-sheet position.

A current assets figure of $380M for 0H22.L is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 0H22.L's current assets ($380M), review year-over-year change from $880M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack BioInvent International AB (publ)'s current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.